A general, ring closure metathesis based enantiospecific approach to polyfunctional eudesmane, eremophilane and agarofuran sesquiterpenoids by Mehta, Goverdhan & Senthil Kumaran, R.
A general, ring closure metathesis based enantiospecific approach
to polyfunctional eudesmane, eremophilane and agarofuran
sesquiterpenoids
Goverdhan Mehta* and R. Senthil Kumaran
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, India
Abstract—An enantiospecific and stereo- and functional group diversity oriented approach to eudesmane, eremophilane and
agarofuran sesquiterpenoids from (−)-carvone has been devised. RCM has been employed as the key reaction to generate the
highly functionalized eudesmane framework. Further elaboration of the eudesmane framework to agarofurans and biogenetic-type
rearrangement to eremophilanes is outlined.
Eudesmane 1 and eremophilane 2 sesquiterpenoid
skeleta based on the bicyclic decalin framework are
fairly widespread in nature and occur in different stereo-
chemical and functionalization patterns.1 Eremophilane
2 represents the earliest known example of an irregular
isoprenoid in nature and in a classical proposal,
Robinson in 19392 invoked a carbonium ion-mediated
methyl migration in eudesmane 1 to explain their bio-
genesis which was subsequently confirmed through
both in vivo and in vitro experiments.3 Another inter-
esting sub-class of natural products derived from eudes-
manes are agarofurans 3 whose polyoxygenated
derivatives, e.g. celorbicol 4 are of wide occurrence,
particularly in the Celastraceae family and many of
them have been found to exhibit broad ranging biolog-
ical activity profiles.4,5 Not surprisingly, eudesmanes,
eremophilanes and particularly agarofurans continue to
evoke a great deal of synthetic interest and many
interesting strategies have been devised to access these
families of sesquiterpenoids.1,6 In particular, extensive
synthetic studies have been directed towards the poly-
hydroxylated agarofurans in view of their biological
potential and the challenge associated with the genera-
tion of the network of hydroxyl functionalities.6 Herein,
we describe a new, general, enantiospecific synthetic
approach towards eudesmanes from (−)-carvone 5
employing a ring closing metathesis (RCM) reaction7 as
the key step and their further elaboration towards
polyfunctional agarofurans as well as biogenetic-type
rearrangement to the eremophilane framework.
The ,-epoxyketone 6,8 readily obtained from (−)-car-
vone 5, on reductive allylation under dissolving metal
conditions charted an interesting course and epimeric
hydroxy-ketones 7 and 8 (45:55), sharing identical
stereo- chemistry at the newly generated quaternary
center were realized (Scheme 1).9 The epimeric nature
of the hydroxy-ketones followed from their oxidation
to the same dione 9 and their formation involving an
eventful fragmentation-realdolization process is
depicted in Scheme 1. It is worth noting that the allyl
group in 7 and 8 is cis with respect to the isopropenyl
group, a situation conducive to accessing eudesmane
based natural products which occur predominantly
with the angular methyl group and the isopropyl group
in a trans arrangement.
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Scheme 1. Reagents and conditions : (i) 30% H2O2, 6N NaOH, MeOH, 0°C, 92%; (ii) Li, liq. NH3, CH2CHCH2Br, Et2O, −78°C,
60%; (iii) PCC, DCM, 88%.
Addition of the Grignard reagent derived from 3-
chloro-1-butene to the major -hydroxy-ketone 8 in the
presence of Ce(III) furnished two diastereomeric addi-
tion products 10 and 11 (55:45) (Scheme 2). Interest-
ingly, the Grignard reagent addition to the carbonyl
group of 8 was -face selective to furnish 10 and 11
with the two allyl side arms in cis disposition. Both 10
and 11 were now set for the RCM reaction to generate
the eudesmane framework. Indeed, exposure of 10 and
11 to Grubbs’ catalyst [benzylidene-bis(tricyclo-
hexylphosphine)-dichlororuthenium] resulted in smooth
and efficient conversion to bicycles 12 and 13, respec-
tively (Scheme 2)9 and their stereostructures were
secured through the X-ray crystal structure determina-
tion of the PNB-derivative of 12.10 Thus, in a short
sequence from carvone 5, highly functionalized eudes-
manes 12 and 13 could be accessed, paving the way for
further transformations.
Polyfunctional dihydroxyeudesmane 13 was well-poised
for further elaboration to the eremophilane ring system
2. The monobenzoate 14 derived from 13 was smoothly
and regioselectively dehydrated to the bicyclic triene 15
(Scheme 3).9 The exocyclic double bond in 15 could be
regioselectively hydrated through oxymercuration to
furnish the tertiary alcohol 16.9 Further epoxidation of
16 was stereoselective but exhibited only 4:1 regioselec-
tivity and a 4:1 mixture of -epoxides 17 and 18 was
obtained (Scheme 3). Exposure of the major epoxide 17
to BF3-etherate and hydrolysis of the intermediate enol-
benzoate 19, formed through sequential methyl and
hydrogen migrations, resulted in the eremophilane
keto-diol 20 in good yield (Scheme 3).9 The olefinic
moiety in 20 was further hydroxylated with OsO4 to
furnish polyfunctional eremophilane 21 whose
stereostructure was secured through single crystal X-ray
structure determination.10
As per our plan, dihydroxyeudesmane derivative 13
appeared to be serviceable for elaboration to the agaro-
furan framework 3, particularly because the C4 -
methyl stereochemistry present in it is widespread
among natural products of this class. However, in the
biologically more important agarofurans, the C9
hydroxyl group is usually -oriented, see celorbicol 4.
Our first effort therefore was to carry out a Mitsunobu
type reaction on 13 to invert the C9 hydroxy group
stereochemistry but these efforts were not successful.
Consequently, 13 was oxidised to ketone 22 (X-ray
crystal structure)10 and its reduction with sodium boro-
Scheme 2. Reagents and conditions : (i) CH2CHCH(CH3)MgCl, anhyd. CeCl3, THF, −78°C, 95%; (ii) Grubbs’ cat. (7 mol%),
C6H6, 85°C, 89%; (iii) Grubbs’ cat. (5 mol%), C6H6, 85°C, 95%; (iv) p-NO2C6H4COCl, Et3N, DCM, rt, 90%.
Scheme 3. Reagents and conditions : (i) C6H5COCl, Et3N, DMAP, DCM, rt, 90%; (ii) SOCl2, pyridine, −35°C, 85%; (iii) Hg(OAc)2,
cat. AcOH, THF:H2O, rt, 75%; (iv) mCPBA, NaHCO3, DCM, 83%; (v) BF3·Et2O, DCM, 0°C, 80%; (vi) K2CO3, MeOH, rt, 95%;
(vii) OsO4, NMMO, CH3COCH3:H2O, rt, 92%.
hydride led to a readily separable 4:1 mixture of 13 and
the epimeric diol 23. Although the stereoselectivity in
this reaction to access desired 23 was not satisfactory,
13 could be recycled via 22 to build reasonable quanti-
ties of 23 (Scheme 4).9 Monobenzoate 24 derived from
23 was dehydrated to furnish triene 25 regioselectively
(Scheme 4). Oxymercuration of 25 was regioselective at
the terminal olefinic moiety and readily led to the
tertiary alcohol 26.9 Catalytic OsO4-mediated dihydroxyl-
ation in 26 was stereoselective and acetonide protec-
Scheme 4. Reagents and conditions : (i) PCC, DCM, rt, 78%; (ii) NaBH4, MeOH, 0°C, 90%; (iii) C6H5COCl, Et3N, DMAP, DCM,
rt, 87%; (iv) SOCl2, pyridine, −35°C, 80%; (v) Hg(OAc)2, cat. AcOH, THF:H2O, rt, 70%; (vi) (a) OsO4, NMMO,
CH3COCH3:H2O, rt, 95%; (b) CH3COCH3, Amberlyst, rt, 81%; (vii) mCPBA, NaHCO3, DCM, 90%; (viii) TMSOTf, DCM, 0°C,
55%.
tion led to the polyfunctional 27 (Scheme 4). As the
-face of 27 was sterically shielded, epoxidation of 27
was stereoselective and furnished exclusively the -
epoxide 28. Brief exposure of 28 to TMSOTf led to the
contemplated tetrahydrofuran formation through epox-
ide opening and capture by the tertiary hydroxyl group
to lead to agarofuran derivative 29. The complete
stereostructure of 29 was confirmed through its X-ray
crystal structure determination.10 Access to the agaro-
furan 29 with secured stereochemistry at eight stereo-
genic centers and five oxygen functionalities,
particularly with C6 and C9 hydroxyl groups, makes
our approach amenable to adaptation for the synthesis
of many natural products of this family.
In summary, we have outlined a new approach to
assemble rapidly, strategically functionalized eudes-
manes from (−)-carvone employing RCM as the key
step. Further transformations involving functional
group amplification and rearrangements provide entry
into polyoxyfunctionalized eremophilanes and
agarofurans.
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J=7.8 Hz, 3H), 1.15 (s, 3H); 13C NMR (75 MHz) 
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J=6.6 Hz, 1H), 2.97 (s, 1H), 2.68–2.65 (m, 1H), 2.45 (m,
1H), 2.18 (d, J=17.7 Hz, 1H), 1.84–1.81 (m, 2H), 1.75 (s,
3H), 1.31–1.23 (m, 1H), 1.16 (s, 3H), 0.99 (d, J=7.5 Hz,
3H); 13C NMR (75 MHz)  149.5, 130.6, 122.8, 109.1,
77.4, 76.1, 39.2, 38.5, 36.1, 33.9, 33.5, 31.9, 20.9, 18.8,
13.2; HRMS calcd for 259.1674 (M+Na). Found
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10. X-Ray crystal structure determination: X-ray data were
collected at 293 K on a SMART CCD–BRUKER dif-
fractometer with graphite monochromated MoK radia-
tion (=0.7107 A ). Structure was solved by direct
methods (SIR92). Refinement was by full-matrix least-
squares procedures on F2 using SHELXL-97. The non-
hydrogen atoms were refined anisotropically whereas
hydrogen atoms were refined isotropically. Compound
PNB derivative of 12: C22H27O5N, MW=385.45, crystal
system: monoclinic, space group: P2(1), cell parameters:
a=8.265 (2), b=13.123 (3), c=18.829(5) A , =
94.113(5), V=2037.09(6) A 3, Z=4, Dcalcd=1.257 g cm−3,
F(000)=824.0, =0.09 mm−1. Total number of l.s.
parameters=721, R1=0.0576 for 6673, Fo>4(Fo) and
0.0797 for all 8820 data. WR2=0.1213, GOF=1.123.
Restrained GOF=1.123 for all data. There are two
molecules in an asymmetric unit. An ORTEP diagram
with only one molecule is shown in Scheme 2. (CCDC
214302). Compound 21: C15H26O5, MW=286.37, color-
less crystal, Crystal system: monoclinic, space group:
P2(1), cell parameters: a=7.6151(6), b=12.361(1), c=
16.356(1) A , V=1539.76 A 3, Z=4, Dcalcd=1.235 g cm−3,
F(000)=624.0, =0.09 mm−1. Total number of l.s.
parameters=285, R1=0.0385 for 2927, Fo>4(Fo) and
0.0417 for all 53125 data. WR2=0.0925, GOF=1.086.
Restrained GOF=1.086 for all data (CCDC 214303).
Compound 22: C15H22O2, MW=234.34, colorless crystal,
crystal system: monoclinic, space group: P2(1), cell
parameters: a=10.305(2), b=10.916(2), c=12.805(3) A ,
=108.436(4), V=1366.75(6) A 3, Z=4, Dcalcd=1.139 g
cm−3, F(000)=512.0, =0.07 mm−1. Total number of l.s.
parameters=315, R1=0.0565 for 4301, Fo>4(Fo) and
0.0739 for all 5368 data. WR2=0.1254, GOF=1.106,
restrained GOF=1.106 for all data. There are two
molecules in an asymmetric unit. (CCDC 214304).
Compound 29: C22H30O6, MW=390.48, crystal system:
monoclinic, space group: P2(1), cell parameters: a=
8.198(2), b=15.354(4), c=16.138 (4) A , =94.364 (5),
V=2025.55 A 3, Z=4, Dcalcd=1.28 g cm−3, F(000)=
840.0, =0.09 mm−1. Total number of l.s. parameters=
239, R1=0.0897 for 5614, Fo>4(Fo) and 0.1226 for all
7976 data. wR2=0.2182, GOF=1.025, Restrained
GOF=1.025 for all data. There are two molecules in an
asymmetric unit. (CCDC 214305).
